摘要 |
HIV protease inhibitors, obtainable by chemical synthesis, block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and possibly other anti-viral agents as ingredients, are thus suitable for the treatment of the HIV virus known to cause AIDS. |
申请人 |
AGOURON PHARMACEUTICALS, INC.;REICH, SIEGFRIED, H.;PINO, MARK, J.;NGUYEN, DZUY, T.;TRIPPE, ANTHONY, J. |
发明人 |
REICH, SIEGFRIED, H.;PINO, MARK, J.;NGUYEN, DZUY, T.;TRIPPE, ANTHONY, J. |